Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug. The company went IPO on 2024-03-22. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Follow-Up Questions
Qui est le CEO de Galderma Group AG ?
Dr. Flemming Ornskov est le Chief Executive Officer de Galderma Group AG, il a rejoint l'entreprise depuis 2019.
Quelle est la performance du prix de l'action GALDY ?
Le prix actuel de GALDY est de $35.15, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Galderma Group AG ?
Galderma Group AG appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quelle est la capitalisation boursière de Galderma Group AG ?
La capitalisation boursière actuelle de Galderma Group AG est de $41.2B
Est-ce que Galderma Group AG est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 16 analystes ont établi des notations d'analystes pour Galderma Group AG, y compris 6 achat fort, 9 achat, 4 maintien, 0 vente et 6 vente forte
